findmyKOL
Clinical trialNCT00830804CompletedPhase 2Interventional

Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults

SponsorAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsEnrollment113HIV-1 Infections
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alabamatherapeutics Crs

    Birmingham, Alabama, United States

  • Stanford Crs

    Palo Alto, California, United States

  • Ucsd, Avrc Crs

    San Diego, California, United States

  • Ucsf Aids Crs

    San Francisco, California, United States

  • University of Colorado Hospital Crs

    Aurora, Colorado, United States

  • Georgetown University Crs

    Washington D.C., District of Columbia, United States

  • Northwestern University Crs

    Chicago, Illinois, United States

  • Beth Israel Deaconess Med Center

    Boston, Massachusetts, United States

  • Brigham and Women'S Hosp. Actg Crs

    Boston, Massachusetts, United States

  • Washington U Crs

    St Louis, Missouri, United States

  • Aids Community Health Ctr. Actg Crs

    Rochester, New York, United States

  • Unc Aids Crs

    Chapel Hill, North Carolina, United States

  • Duke Univ. Med. Ctr. Adult Crs

    Durham, North Carolina, United States

  • Univ. of Cincinnati Crs

    Cincinnati, Ohio, United States

  • Case Crs

    Cleveland, Ohio, United States

  • Metrohealth Crs

    Cleveland, Ohio, United States

  • the Ohio State Univ. Aids Crs

    Columbus, Ohio, United States

  • Hosp. of the Univ. of Pennsylvania Crs

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Ctu

    Pittsburgh, Pennsylvania, United States

  • the Miriam Hospital

    Providence, Rhode Island, United States

  • Vanderbilt Therapeutics Crs

    Nashville, Tennessee, United States

  • Houston Aids Research Team

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2009
Primary completion
28 Feb 2010
Completion
30 Sept 2010
Last update posted
8 Nov 2018
Registered enrollment
113
Registry id
NCT00830804

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.